Dr. Tushar A. Chopra, MD

Dr. Chopra practices at UVA University Medical Center in Charlottesville, Virginia.

Dr. Chopra's NPI, 1629359013, was assigned on August 30, 2011. Dr. Chopra graduated from KJ Somaiya Medical College in 2008. Dr. Chopra holds Virginia license 0101258333.

Dr. Chopra's primary practice is UVA University Medical Center, at 1215 Lee St, Charlottesville, VA 22908 in Charlottesville City. The practice phone is (434) 760-3439.

Dr. Chopra's primary practice is UVA University Medical Center in Charlottesville, Virginia. Dr. Chopra is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Chopra to 3 more hospitals, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chopra practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Chopra's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Chopra is board certified in internal medicine by the American Board of Internal Medicine. Dr. Chopra is licensed in Virginia.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia, kidney disease and parathyroid gland disorder among the conditions Dr. Chopra treats.

CMS data shows 743 Medicare services from Dr. Chopra across 12 procedure codes in 2024, for 321 Medicare patients. Medicare paid $58,790 for them.

CMS counts 321 Medicare patients who saw Dr. Chopra in 2024. The largest group is 75 to 84, with 123 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 3.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chopra's median patient age at 64, with 50% women.

In 2024, Dr. Chopra wrote 574 Medicare Part D claims for 111 patients. 83% of them were for generic drugs. CMS names the drug for 417 of them, across 11 drugs with 11 or more claims each, at $76,321 in total drug cost. In 2023, CMS named 447 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Chopra for performance year 2024, reported as part of a group. Dr. Chopra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chopra as offering telehealth.

Dmand AI links 13 papers to Dr. Chopra, published from 2016 to 2023. 2016 was the busiest year, with 3. The most frequent topics are Kidney Failure, Chronic, Renal Dialysis and Acute Kidney Injury. Dr. Chopra has published most often in Hemodial Int. Dr. Chopra's most frequent co-authors are Rakesh Malhotra, MD, MPH, Joachim Hanno Ix, MD and Pranav Sandilya Garimella, MD.

CMS Open Payments shows 2 general payments to Dr. Chopra from 2 drug and device companies in 2024. Food and beverage make up the largest share, 100% of the total. Baxter Healthcare paid the most, $33.

Dr. Chopra graduated from KJ Somaiya Medical College in 2008.

Dr. Chopra is in network with 16 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.